相关实验视频
Updated: Jan 15, 2026

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.6K
亚洲卵巢癌负担的区域异质性和未来挑战
Heng Zhang1, Jian Chen2, Dongzi Li1
1Department of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
The journal of obstetrics and gynaecology research
|January 14, 2026
概括
由于老龄化和人口增长,亚洲部分地区的卵巢癌负担正在上升. 需要有针对性的战略来解决差异,并减轻未来的发病率和死亡率的增加.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 卵巢癌 (OC) 在亚洲是一个日益严重的公共卫生挑战,其发病率越来越高,区域差异很大.
- 该研究利用2021年全球疾病负担 (GBD) 数据集来分析亚洲的疾病负担趋势和决定因素.
研究的目的:
- 评估1990年至2021年亚洲卵巢癌负担的时间趋势和空间模式.
- 确定影响卵巢癌发病率,死亡率和残疾调整寿命年的关键决定因素.
- 预测到2036年亚洲未来的卵巢癌负担.
主要方法:
- 使用GBD 2021数据对年龄标准化发病率,死亡率和残疾调整寿命年率 (ASIR,ASMR,ASDR) 的分析.
- 通过估计年度百分比变化 (EAPC) 和连接点回归来评估趋势.
- 人口驱动因素的分解分析和发生率效应的年龄周期队列 (APC) 分析;未来预测的自回归集成移动平均线 (ARIMA).
主要成果:
- 卵巢癌的负担从1990年到2021年显著增加,在东南亚,南亚和中亚地区的增长最高.
- 较高的社会人口统计指数 (SDI) 与发病率和死亡率的增加相关;老龄化在东亚带来负担,而人口增长在南亚占主导地位.
- 在APC分析中,年龄被确定为主要的风险因素,随着周期增长和队列效应下降. 预测表明ASIR稳步增长和U形ASMR/ASDR轨迹.
结论:
- 东南亚,南亚和中亚的卵巢癌负担不断升级,迫切需要针对特定地区的公共卫生战略.
- 关键干预措施应侧重于早期诊断,公平获得医疗保健,并解决人口和流行病学驱动因素.
- 实施有针对性的战略至关重要,以减轻到2036年预计的卵巢癌负担的增加.
相关概念视频
Oogenesis
69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

